Giuseppina Novo

Aging in cardio-oncology: Pathophysiology, clinical implications and future directions.

Population aging is changing the needs of patients seen in cardio-oncology. Older adults with cancer often have cardiovascular disease, multimorbidity, and reduced physiological reserve, which can complicate treatment and recovery. Patients of the same chronological age may differ considerably in cardiovascular health,...

VALVE DISEASES IN CARDIAC AMYLOIDOSIS: WHAT WE HAVE TO KNOW.

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular deposition of amyloid fibrils, most commonly derived from immunoglobulin light chains (AL) or transthyretin (ATTR). While myocardial involvement has been extensively characterized, valvular disease in CA has received comparatively less a...

Long-term outcomes of transcatheter mitral valve repair in patients with cancer: a systematic review and meta-analysis.